Concepedia

Author

Barbara Peil

Boehringer Ingelheim (Germany)

Also Known As

B Peil, B. Peil, BARBARA PEIL, Barbara Peil, Peil, Barbara

33

Publications

1.8K

Citations

15

H-Index

40

Concepts

All Affiliations

Boehringer Ingelheim (Germany)Heidelberg UniversityGerman Centre for Cardiovascular ResearchWroclaw Medical UniversityHarvard University
BP

About

Barbara Peil is an author at Boehringer Ingelheim (Germany) specializing in medicine, lung cancer, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

212

2

Health Sciences

1

1

32

3

Natural Sciences

1

1

43

4

Public Health

1

1

62

5

Epidemiology

1

1

62

Barbara Peil

×

15

Publications

1.7K

Citations

14

H-Index

YearCitations

Atlas of the clinical genetics of human dilated cardiomyopathy

Jan Haas, Karen Frese, Barbara Peil,

European Heart Journal

2014

556

Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes

William T. Abraham, JoAnn Lindenfeld, Piotr Ponikowski,

European Heart Journal

2020

203

Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial

Javed Butler, Stefan D. Anker, Gerasimos Filippatos,

European Heart Journal

2020

174

A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy

Benjamin Meder, Frank Rühle, Tanja Weis,

European Heart Journal

2013

171

Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headache

Bernhard Aicher, Hubertus Peil, Barbara Peil,

Cephalalgia

2011

162

Subtypes of Native American ancestry and leading causes of death: Mapuche ancestry-specific associations with gallbladder cancer risk in Chile

Justo Lorenzo Bermejo, Felix Boekstegers, Rosa González Silos,

PLoS Genetics

2017

62

Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials

Yi‐Long Wu, Lecia V. Sequist, Eng-Huat Tan,

Clinical Lung Cancer

2018

62

Rationale and Design of The Emperial-Preserved and Emperial-Reduced Trials of Empagliflozin in Patients with Chronic Heart Failure

William T. Abraham, Piotr Ponikowski, Martina Brueckmann,

European Journal of Heart Failure

2019

58

Weight Change and Clinical Outcomes in Heart Failure with Reduced Ejection Fraction: Insights from EMPEROR-Reduced

Stefan D. Anker, Muhammad Shahzeb Khan, Javed Butler,

European Journal of Heart Failure

2022

49

Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4

David Scherf, N. K. Sarkisyan, Hanna Jacobsson,

Oncogene

2012

43

Page 1